Accueil   Diary - News   All news BIOCORP announces Partnership with AARDEX Group to Extend Smart Solutions for Precision Medication Adherence

BIOCORP announces Partnership with AARDEX Group to Extend Smart Solutions for Precision Medication Adherence

 

 

 

By combining their key technologies, both companies offer innovative specific solutions for clinical trials and numerous commercial applications

 


Issoire (France), October 1st, 2020, at 07:30 am CEST - BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the design, development and manufacture of innovative medical devices, today announced an alliance with Belgium-based AARDEX Group, the world leader in medication adherence solutions.


This alliance is to combine BIOCORP’s connected add-on solutions for drug delivery devices with AARDEX’s proprietary Medication Event Monitoring System (MEMS®) and offer a comprehensive solution to patients and healthcare providers to effectively measure and manage medication adherence. 

 

Read the press release